March 3, 2015

Celldex Therapeutics Announces Upcoming Presentation at the Cowen and Company 35th Annual Health Care Conference

HAMPTON, N.J., March 3, 2015 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that the Company is scheduled to present a corporate overview at the Cowen and Company 35th Annual Health Care Conference on Wednesday, March 4, at 8:40 am ET at the Boston Marriott Copley Place Hotel in Boston, MA.

A live webcast of the presentation will be available online on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. A replay of the presentation will be available through March 11, 2015.

About Celldex Therapeutics, Inc.

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response. Visit www.celldex.com.

CONTACT: Celldex Company Contacts:

         Investors:

         Sarah Cavanaugh

         Vice President of Investor Relations &

         Corp Communications

         Celldex Therapeutics, Inc.

         (781) 433-3161

         scavanaugh@celldex.com

         or

         Media:

         Dan Budwick

         Pure Communications, Inc.

         (973) 271-6085

         dan@purecommunicationsinc.com

Celldex Therapeutics logo

Source: Celldex Therapeutics, Inc.

News Provided by Acquire Media


Close window | Back to top

Copyright 2017 Celldex Therapeutics, Inc.